Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Advances in the diagnosis and management of neurocysticercosis
Jose A. Serpa
, Linda S. Yancey
,
Arthur Clinton White
Internal Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
34
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advances in the diagnosis and management of neurocysticercosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Neurocysticercosis
100%
Host Inflammation
33%
Developing Countries
33%
Clinical Manifestations
33%
Pathogenic Mechanism
33%
Most Common Cause
33%
Causative Agents
33%
Recent Advances
33%
Anti-inflammatory Drugs
33%
Taenia Solium
33%
Serological Diagnosis
33%
Optimal Treatment
33%
Antiparasitic Drugs
33%
Antiepileptic Drugs
33%
Diagnostic Techniques
33%
Larval Stages
33%
Symptomatic Therapy
33%
Late-onset Epilepsy
33%
Advances in Neuroimaging
33%
Medicine and Dentistry
Neurocysticercosis
100%
Diseases
66%
Parasite (Microbiology)
33%
Antiinflammatory Agent
33%
Taenia Solium
33%
Antiparasitic Agent
33%
Larval Stage
33%
Epilepsy
33%
Inflammation
33%
Pathogenesis
33%
Diagnosis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neurocysticercosis
100%
Diseases
66%
Inflammation
33%
Antiinflammatory Agent
33%
Antiparasitic Agent
33%
Taenia Solium
33%
Epilepsy
33%
Pathogenesis
33%
Parasite
33%
Immunology and Microbiology
Neurocysticercosis
100%
Taenia Solium
33%
Larval Stage
33%
Inflammation
33%
Parasite
33%